At CareBiom, we employ rigorous translational science to discover novel medicines for cancer patients. Our Translational Sciences team acts as the bridge between microbiome research and clinical development, innovating in both science and process to accelerate the development of cancer quality of life programs that can make a meaningful difference for patients.
What we learn from the data on microbiome and cancer treatment, we leverage to improve future cancer treatment. As a team and an organization,
we thrive on scientific challenge and strive to deliver transformational therapies for patients.